Aubrey L. Gilbert

Aubrey L. Gilbert

Auto-generated profile, based on publicly available information

Aubrey L. Gilbert

Kaiser Permanente Northern California, Department of Ophthalmology, Vallejo, CA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Survey of Ophthalmology
Verified
Journal Article
Closed access
MZMia Zhang
Mia Zhang
AGAubrey Gilbert
Aubrey Gilbert
DHDavid G. Hunter
David G. Hunter

10 January 2023 in Ophthalmology Retina
Verified
Journal Article
Closed access
RSRonak Shah
Ronak Shah
AGAubrey Gilbert
Aubrey Gilbert
RMRonald Melles
Ronald Melles
APAmar Patel
Amar Patel
TDTimothy Do
Timothy Do
RVRobin A. Vora
Robin A. Vora

26 December 2023 in Ophthalmology Retina
Verified
Journal Article
Closed access
RSRonak Shah
Ronak Shah
XZXuwen Zheng
Xuwen Zheng
APAmar P. Patel
Amar P. Patel
MBM. Tariq Bhatti
M. Tariq Bhatti
AGAubrey Gilbert
Aubrey Gilbert
RVRobin A. Vora
Robin A. Vora

1 July 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
AGAyse Gungor
Ayse Gungor
ISIlias Sarbout
Ilias Sarbout
AGAubrey L. Gilbert
Aubrey L. Gilbert
SHSteffen Hamann
Steffen Hamann
PLPierre Lebranchu
Pierre Lebranchu
DMDan Milea
Dan Milea
Background: Prompt diagnosis of acute central retinal artery occlusion (CRAO) is crucial for therapeutic management and stroke prevention. However, most stroke centers lack onsite ophthalmic expertise before considering fibrinolytic treatment. This study aimed to develop, train, and test a deep learning system to detect hyperacute CRAO on retinal fundus photographs within the critical 4.5‐hour treatment window and up to 24 hours after visual loss to aid in secondary stroke prevention. Methods: Our retrospective, cross‐sectional study included 1322 color fundus photographs from 771 patients with acute visual loss due to CRAO, central retinal vein occlusion, nonarteritic anterior ischemic optic neuropathy, and healthy controls. Photographs were collected from 9 expert neuro‐ophthalmology centers in 6 countries, including 3 randomized clinical trials. Training included 1039 photographs (517 patients), followed by testing on 2 data sets: (1) hyperacute CRAO (54 photographs, 54 patients) and (2) CRAO within 24 hours after visual loss (110 photographs, 109 patients). Results: The deep learning system achieved an area under the receiver operating characteristic curve of 0.96 (95% confidence interval (CI), 0.95–0.98), a sensitivity of 92.6% (95% CI, 87.0–98.0), and a specificity of 85.0% (95% CI, 81.8–92.8) for detecting CRAO at hyperacute stage, with similar results within 24 hours. The deep learning system outperformed stroke neurologists on a subset of hyperacute testing data set (120 photographs, 120 patients). Conclusions: A deep learning system can accurately detect hyperacute CRAO on retinal photographs within a time window compatible with urgent fibrinolysis. If further validated, such systems could improve patient selection for fibrinolytic trials and optimize secondary stroke prevention. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT06390579.

1 January 2015 in International Ophthalmology Clinics
Verified
Journal Article
Closed access
AGAubrey L. Gilbert
Aubrey L. Gilbert
CCCatherine Choi
Catherine Choi
SLSimmons Lessell
Simmons Lessell

7 February 2026 in Ophthalmology Retina
Verified
Journal Article
Closed access
DLDaniel Lee
Daniel Lee
HEHannah El-Sabrout
Hannah El-Sabrout
RSRonak Shah
Ronak Shah
AGAubrey L. Gilbert
Aubrey L. Gilbert
APAmar Patel
Amar Patel
RVRobin A. Vora
Robin A. Vora